Editor’s ChoiceAcademic JournalMain Category: HIV / AIDS Article Date: 05 Apr 2013 – 0:00 PDT email to a friend printer friendly opinions <!– rate article Ad For Health Professionals Patient / Public: 5 (1 votes) Healthcare Prof: Researchers have charted a new route that could help develop a vaccine to boost a…
Although effective therapy for tuberculosis is available, TB continues to cause significant problems worldwide, and rates of multi-drug resistant (MDR) TB cases are on the rise. A major obstacle to the control of TB is poor adherence with lengthy (usually 6 months) and complicated treatment regimens. Incomplete TB treatment can lead to serious consequences such…
Main Category: HIV / AIDS Also Included In: Immune System / Vaccines Article Date: 05 Apr 2013 – 0:00 PDT email to a friend printer friendly opinions <!– rate article Ad For Health Professionals Patient / Public: Healthcare Prof: By tracking the very earliest days of one person’s robust immune response to…
Tuberculosis (TB) is the second most deadly infectious disease after HIV. Multidrug-resistant TB (MDR-TB) has emerged as a worldwide epidemic, limiting treatment options. HIV infected people with suppressed immune systems are particularly susceptible to TB, and TB is the leading cause of death among people with HIV. Treating people infected with both HIV and TB…
This Stage II randomized trial tests Culturally Informed Flexible Family Based Treatment for Adolescents (CIFFTA) developed as part of a Stage I treatment development effort and yielding promising preliminary findings. Drug use rates are highest among Hispanic middle school youth and to date no treatments have met criteria for “Well Established” in the treatment of…
A reformulated version of an anti-HIV gel developed for vaginal use was found safe and acceptable by HIV-negative men and women who used it rectally, according to a Phase I clinical trial published in PLOS ONE. The study, led by researchers with the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), tested a…
Impairment in neurocognitive(NC) function in HIV-infected subjects in the current anti-retroviraltreatment (cART) era has been associated with poor compliance with cART, reduced quality-of-life and increased mortality. Reported factors associated with the development of NC function impairment in HIV disease and risks associated with progression of such impairment include degree of immune suppression related to HIV…
